DABR Archives - Sidra Medicine

Khalid Al-Dasuqi

Dr. Khalid Al-Dasuqi is an Attending Physician in Pediatric Neuroimaging at Sidra Medicine and Associate Program Director of the Pediatric Radiology Fellowship. He is a board-certified diagnostic radiologist and diplomate of the American Board of Radiology with subspecialty certification in pediatric radiology. He joined Sidra Medicine in 2024, bringing a strong academic and clinical background in advanced pediatric imaging.

Dr. Al-Dasuqi earned his medical degree with academic distinction from Weill Cornell Medicine–Qatar and completed his residency in diagnostic radiology at Yale–New Haven Hospital/Yale School of Medicine, where he served as Chief Resident. He then pursued dual fellowships in pediatric radiology and pediatric neuroradiology at Boston Children’s Hospital/Harvard Medical School.

His areas of expertise include pediatric neuro-oncology, brain malformations, fetal and neonatal imaging, and head and neck imaging. Dr. Al-Dasuqi is also passionate about imaging informatics, artificial intelligence in workflow optimization, and medical education, with more than 20 peer-reviewed publications and numerous international conference presentations.

9 November, 2025

Sidra Medicine Launches Seminar Series on Processes for Reporting Child Abuse

Sidra Medicine, a member of Qatar Foundation, has launched a series of free online seminars on how to report child abuse. Titled “Multidisciplinary Approaches to Child Abuse: Prevention, Intervention, and Support”, the seminars by the Sidra Medicine’s Child Advocacy Program (SCAP), is targeted at physicians, nurses and allied health professionals.

5 November, 2025

Sidra Medicine Introduces Qatar’s First Autologous Serum Eye Drops

Sidra Medicine, a member of Qatar Foundation, has announced the launch of Qatar’s first Autologous Serum Eye Drops, a prescription-based treatment developed for patients with severe dry eye disease and related ocular surface conditions.

2 November, 2025

Sidra Medicine to Host Qatar Advancements in Pediatric Excellence Conference (QAPEX 2025)

Sidra Medicine, a member of Qatar Foundation, will host the Qatar Advancements in Pediatric Excellence (QAPEX) Conference on 21 and 22 November 2025 at Al Sharq Village Hotel in Doha, Qatar.

28 October, 2025

Sidra Medicine to Host Neonatal Respiratory Care Conference

Sidra Medicine, a member of Qatar Foundation, will host its first Neonatal Respiratory Care Conference from 13 to 15 November 2025 in Doha, Qatar. Themed as “Tiny Breaths, Big Futures: Updates and Controversies in Neonatal Respiratory Care”, the event is set to explore innovative strategies, share best practices, and foster collaboration in the realm of neonatal respiratory care.

23 October, 2025

Denovo Sciences, Sidra Medicine, and Weill Cornell Medicine-Qatar Announce Collaboration to Discover Drug Candidates for Homocystinuria

Denovo Sciences Inc., a pioneer in AI-driven drug discovery based on synthetic data, Weill Cornell Medicine-Qatar (WCM-Q), a leading biomedical research and educational institution, and Sidra Medicine, a women’s and children’s healthcare organization, are engaging in a collaboration to identify and develop novel drug candidates for homocystinuria, a rare and genetic metabolic disorder.

21 October, 2025

Sidra Medicine and BenevolentAI Collaborate to Advance Diabetes Research Through AI

Sidra Medicine, a member of Qatar Foundation, has announced a research collaboration with BenevolentAI to investigate the potential role of the gene ZFP57 in diabetes and metabolic regulation. The project represents a proof-of-concept that applies AI to accelerate biomedical discovery.

14 October, 2025

Sidra Medicine to Host 5th Annual Pediatric Neuroscience Conference

14 October 2025—Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, will host its 5th annual Pediatric Neuroscience Conference (PNC) from 6 to 8 November 2025 at the Marriott Marquis City Center in Doha, Qatar.

8 October, 2025

Sidra Medicine signs MoU with Qatari Business Women’s Association (QBWA)

Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with the Qatari Business Women’s Association (QBWA) to promote collaboration in areas that support women’s advancement, leadership, and health.

29 September, 2025

Her Highness Sheikha Moza bint Nasser Attends Sidra Medicine’s Disease Modeling and Therapeutics Conference

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development (QF) today attended Sidra Medicine’s first Disease Modeling and Therapeutics (DMT) conference.